bullish
Smartkarma Webinar | 2021 High Conviction - Investment Opportunities in China's Healthcare Industry
593 Views11 Jan 2021 16:50
SUMMARY
We start off 2021 with a look into China's healthcare industry and the opportunities therein. For this session, we are excited to be joined by Xinyao (Criss) Wang , who will share her high-conviction ideas for the coming year.
Xinyao (Criss) Wang is a HK/China Healthcare Analyst with over 10 years of experience in both finance and healthcare, covering clinic operations, investment, and equity research both in China and overseas.
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Discussions
(Paid Plans Only)
- Smartkarma Webinar | 2021 High Conviction - Investment Opportunities in China's Healthcare Industry11 Jan 2021
- Livzon Pharmaceutical (000513.CH) - A Good Company that You Can't Afford Missing02 Dec 2020
- Pre-IPO Harbour Biomed (2142.HK) - Don't Ignore The "Hidden Value"01 Dec 2020
- 2021 High Conviction - Investment Opportunities in China Healthcare Industry23 Nov 2020
x